the way I see it, HPM fellowship is only 1 year, so it's difficult to focus in any one specific niche area of research during that time. This kind of work would fit better over a CAREER, not a single year that is already so busy and demanding in terms of clinical responsibility and personal growth. So I did not consider this as a high priority when considering particular fellowship programs. There are simply so many other factors that matter more and make the year go well, including the personalities of your faculty, the clinical rotations, call schedule, etc.
Also just to nitpick a bit (out of interest), the Johns Hopkins psilocybin trial was with full doses of Psilocybin, not micro doses. Have you heard of anyone doing research on MICRO doses of psilocybin for depression/anxiety in any setting, let alone the terminal ill? Just curious.
Likewise I know MDMA has been found to be highly effective for treating PTSD. However I've never heard of research in micro doses of MDMA. Has a micro dose of MDMA ever been found to help anyone, in any setting, ever?
Ketamine is being used across the country for a ton of indications. I'm forgetting right now which programs that I interviewed at offer that kind of research at the moment. Again, it wasn't a high priority for me for fellowship year but I remain generally interested.